CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
CereCura Nanotherapeutics has raised $998K in total funding. The most recent round was Seed. The last funding was announced in November 2025.
CereCura Nanotherapeutics's investors include UBC Venture Funds, WUTIF, E-Fund, Hextwo Capital.
CereCura Nanotherapeutics is headquartered in Vancouver, Canada.
CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
CereCura Nanotherapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CereCura Nanotherapeutics — Funding & Investors." VCBacked, November 14, 2025, https://www.vcbacked.co/company/cerecura-nanotherapeutics. Accessed October 29, 2026.
VCBacked. (2025). CereCura Nanotherapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/cerecura-nanotherapeutics
{{cite web |title=CereCura Nanotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cerecura-nanotherapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated